Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10835660 | 0.90 | L3MBTL1 (0.41) | ALDH1A1USP2ALOX15TDP1L3MBTL1 | |
| SCHEMBL23466931 | 0.84 | ALDH1A1 (0.43) | ALDH1A1USP2ALOX15TDP1L3MBTL1 | |
| SCHEMBL6312583 | 0.82 | ALDH1A1 (0.38) | ALDH1A1USP2ALOX15TDP1L3MBTL1 | |
| SCHEMBL16599630 | 0.81 | MAPT (0.40) | ALDH1A1USP2ALOX15TDP1NPSR1 | |
| SCHEMBL15974381 | 0.81 | MAPT (0.40) | ALDH1A1USP2ALOX15TDP1NPSR1 | |
| SCHEMBL13766514 | 0.75 | MAPT (0.36) | MAPT | |
| SCHEMBL14572814 | 0.74 | ALDH1A1 (0.45) | ALDH1A1USP2ALOX15TDP1KDM4E | |
| SCHEMBL16614399 | 0.74 | MAPT (0.37) | ALDH1A1USP2ALOX15TDP1NPSR1 | |
| SCHEMBL3401832 | 0.72 | MAPT (0.30) | TDP1MAPT | |
| SCHEMBL10394018 | 0.72 | ALDH1A1 (0.38) | ALDH1A1USP2ALOX15TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11772085-B2 | Far superior oxidation catalysts based on macrocyclic compounds | CARNEGIE MELLON UNIVERSITY (US) | 2023-10-03 | — | — | US | disclosed |
| EP-4015511-A1 | OXIDATION CATALYSTS BASED ON MACROCYCLIC COMPOUNDS | CARNEGIE MELLON UNIVERSITY (US) | 2022-06-22 | — | — | EP | disclosed |
| EP-3353157-B1 | OXIDATION CATALYSTS BASED ON MACROCYCLIC COMPOUNDS | UNIV CARNEGIE MELLON (US) | 2021-11-24 | — | — | EP | disclosed |
| US-20210086171-A1 | FAR SUPERIOR OXIDATION CATALYSTS BASED ON MACROCYCLIC COMPOUNDS | CARNEGIE MELLON UNIVERSITY | 2021-03-25 | — | — | US | disclosed |
| US-10926248-B2 | Far superior oxidation catalysts based on macrocyclic compounds | CARNEGIE MELLON UNIVERSITY (US) | 2021-02-23 | — | — | US | disclosed |
| US-20180304247-A1 | FAR SUPERIOR OXIDATION CATALYSTS BASED ON MACROCYCLIC COMPOUNDS | CARNEGIE MELLON UNIVERSITY | 2018-10-25 | — | — | US | disclosed |
| US-8999913-B2 | Fragrance mixtures containing cyclopent-2-enyl ethyl acetate | SYMRISE AG (DE) | 2015-04-07 | — | — | US | disclosed |
| US-20130172429-A1 | FRAGRANCE MIXTURES CONTAINING CYCLOPENT-2-ENYL ETHYL ACETATE | SYMRISE AG (DE) | 2013-07-04 | — | — | US | disclosed |
| EP-2474301-A1 | Perfume mixtures containing Cyclopent-2-Enyl-ethyl acetate | Symrise AG (DE) | 2012-07-11 | — | — | EP | disclosed |
| US-7060818-B2 | Synthesis of macrocyclic tetraamido compounds and new metal insertion process | CARNEGIE MELLON UNIVERSITY (US) | 2006-06-13 | — | — | US | disclosed |
| WO-2004076425-A1 | IMPROVED SYNTHESIS OF MACROCYCLIC TETRAAMIDO COMPOUNDS AND NEW METAL INSERTION PROCESS | CARNEGIE MELLON UNIVERSITY (US) | 2004-09-10 | — | — | WO | disclosed |
| EP-0914206-B1 | LONG-LIVED HOMOGENOUS OXIDATION CATALYSTS | UNIV CARNEGIE MELLON (US) | 2002-12-11 | — | — | EP | disclosed |
| US-6100394-A | Long-lived homogenous oxidation catalysts | CARNEGIE MELLON UNIVERSITY (US) | 2000-08-08 | — | — | US | disclosed |
| US-6054580-A | STERICALLY HINDERED CROWN COMPOUND LIGAND FOR COMPLEXING WITH TRANSITION METAL AS OXIDATION CATALYST RESISTANT TO OXIDIZER DURING USE | CARNEGIE MELLON UNIVERSITY (US) | 2000-04-25 | — | — | US | disclosed |
| US-6051704-A | REACTING AN AMINO CARBOXYLIC ACID WITH AN ACTIVATED DERIVATIVE SELECTED FROM THE GROUP CONSISTING OF OXALATES AND MALONATES IN THE PRESENCE OF A SUPPORTING SOLVENT AND HEAT TO FORM AN INTERMEDIATE, ADDING A DIAMINE, HEATING | CARNEGIE MELLON UNIVERSITY (US) | 2000-04-18 | — | — | US | disclosed |
| US-6011152-A | REACTING STOICHIOMETRIC AMOUNTS OR MORE OF AN AMINO CARBOXYLIC ACID OR A PROTECTED/ACTIVATED FOR THEREOF WITH AN ACTIVATED DERVATIVE SELECTED FROM THE GROUP CONSISTING OF OXALATES AND MALONATES IN THE PRESENCE OF A SOLVENT AND HEAT | CARNEGIE MELLON UNIVERSITY (US) | 2000-01-04 | — | — | US | disclosed |
| EP-0914206-A1 | LONG-LIVED HOMOGENOUS OXIDATION CATALYSTS | CARNEGIE-MELLON UNIVERSITY (US) | 1999-05-12 | — | — | EP | disclosed |
| WO-1998003263-A1 | LONG-LIVED HOMOGENOUS OXIDATION CATALYSTS | CARNEGIE MELLON UNIVERSITY (US) | 1998-01-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10926248-B2 | Far superior oxidation catalysts based on macrocyclic compounds | ME3, SOD1, DUOX1 | ALDH1A1 1400/4885USP2 3004/4885ALOX15 1021/4885 |
| US-20180304247-A1 | FAR SUPERIOR OXIDATION CATALYSTS BASED ON MACROCYCLIC COMPOUNDS | ME3, SOD1, DUOX1 | ALDH1A1 1400/4885USP2 3004/4885ALOX15 1021/4885 |
| US-11772085-B2 | Far superior oxidation catalysts based on macrocyclic compounds | SOD1, ME3, ME2 | ALDH1A1 1499/4885USP2 2920/4885ALOX15 1140/4885 |
| US-20210086171-A1 | FAR SUPERIOR OXIDATION CATALYSTS BASED ON MACROCYCLIC COMPOUNDS | ME3, ME2, ME1 | ALDH1A1 1801/4885USP2 3389/4885ALOX15 1739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.